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Cryptococcal Empyema: A Rare Manifestation of Disease 
Mohamed Mortagy, MD; Stephen Breisach, MS1; Kevin Kavanaugh, MD
Internal Medicine Department
Introduction
Cryptococcus Neoformans is a pathogenic yeast that is acquired 
from the environment via inhalation. However,  pulmonary 
infection is uncommon. Cryptococcosis usually manifests as a CNS 
or disseminated infection especially in immunocompromised
patients. Infection of the pleural space with C. Neoformans is quite 
uncommon [1].
Case Presentation
A 66 year old man with past medical history of diabetes was 
admitted because of right sided pleuritic chest pain. Patient was 
afebrile and hemodynamically stable. Patient had decreased air 
entry on auscultation of the right lung. Imaging showed loculated
right sided pleural effusion (Figure 1). Pleural fluid culture grew 
Streptococcus Intermedius. A chest tube was placed. He then 
underwent thoracotomy and decortication of the right pleura. As 
well, patient received a complete course of appropriate 
antimicrobials  (i.e., ceftriaxone and metronidazole and then, 
clindamycin after discharge). The pleural peel fungal culture grew 
Cryptococcus Neoformans one month later. 
The patient was thus seen at the Infectious Diseases clinic. He was 
still complaining of ongoing fatigue and right sided pleuritic chest 
pain, but he denied fevers, chills, night sweats, cough, dyspnea, 
headaches, stiff neck, nausea, vomiting and photophobia. Serum 
cryptococcal antigen was positive at 1:80, so he was started on 
oral fluconazole for 4 months along with serial cryptococcal
antigen assays during the treatment course. 
Discussion
Cryptococcal pleural effusions are often reactive and sterile that 
may resolve spontaneously or respond to surgical drainage well [2]. 
The immune status is the most important determinant of the 
subsequent course of the infection by C. Neoformans [3]. Most 
cases of cryptococcal empyemic pleural effusions were limited to 
severe immunosuppressed patients [4]. The factors that determine 
whether an exposed person develops symptomatic infection 
include the inoculum of fungi and/or virulence factors of the 
infecting strain. Unlike bacterial empyema, there is no consensus 
on how to define fungal empyema or specific recommendations 
for treatment including indications for drainage via chest tube. 
Common symptoms include cough, sputum production, 
hemoptysis, dyspnea, chest pain, fever, malaise, night sweats and 
weight loss [5].
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Conclusion
This patient is an example of a changing spectrum of 
cryptococcal pleural disease that is conventionally believed to be 
confined to immunocompromised patients. A serum cryptococcal
antigen was diagnostic in our case and should be included in the 
diagnostic evaluation of unexplained pleural empyema/effusion 
in an immunocompetent patient. Aggressive surgical 
debridement and concurrent antifungal chemotherapy predict a 
successful clinical outcome. 
Figure 1: Right sided loculated pleural effusion
